Literature DB >> 2574568

Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.

W Siess1, E G Lapetina.   

Abstract

Adrenaline or UK 14304 (a specific alpha 2-adrenoceptor agonist) and phorbol ester (phorbol 12,13-dibutyrate; PdBu) or bioactive diacylglycerols (sn-1,2-dioctanoylglycerol; DiC8) synergistically induced platelet aggregation and ATP secretion. The effect on aggregation was more pronounced than the effect on secretion, and it was observed in aspirinized, platelet-rich plasma or suspensions of washed aspirinized platelets containing ADP scavengers. No prior shape change was found. In the presence of adrenaline, DiC8 induced reversible aggregation and PdBu evoked irreversible aggregation that correlated with the different kinetics of DiC8- and PdBu-induced protein kinase C activation. Adrenaline and UK 14304 did not induce or enhance phosphorylation induced by DiC8 or PdBu of myosin light chain (20 kDa), the substrate of protein kinase C (47 kDa), or a 38 kDa protein. Immunoprecipitation studies using a Gcommon alpha antiserum or a Gi alpha antiserum showed that Gi alpha is not phosphorylated after exposure of platelets to PdBu or PdBu plus adrenaline. Adrenaline, PdBu or adrenaline plus PdBu did not cause stimulation of phospholipase C as reflected in production of [32P]phosphatidic acid. Adrenaline caused a small increase of Ca2+ in the platelet cytosol of platelets loaded with Indo-1; this effect was also observed in the absence of extracellular Ca2+. However, under conditions of maximal aggregation induced by adrenaline plus PdBu, no increase of cytosolic Ca2+ was observed. Platelet aggregation induced by PdBu plus adrenaline was not inhibited by a high intracellular concentration of the calcium chelator Quin-2. These experiments indicate that alpha 2-adrenoceptor agonists, known to interact with Gi, and protein kinase C activators synergistically induced platelet aggregation through a novel mechanism. The synergism occurs distally to Gi protein activation and protein kinase C-dependent protein phosphorylation and does not involve phospholipase C activation or Ca2+ mobilization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574568      PMCID: PMC1133440          DOI: 10.1042/bj2630377

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.

Authors:  K H Jakobs; W Saur; G Schultz
Journal:  J Cyclic Nucleotide Res       Date:  1976 Nov-Dec

2.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

3.  Effects of catecholamines on the formation of adenosine 3':5'-cyclic monophosphate in human blood platelets.

Authors:  R J Haslam; A Taylor
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

4.  ADP-ribosylation of membrane components by pertussis and cholera toxin.

Authors:  F A Ribeiro-Neto; R Mattera; J D Hildebrandt; J Codina; J B Field; L Birnbaumer; R D Sekura
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis.

Authors:  S P Watson; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets.

Authors:  D E MacIntyre; A McNicol; A H Drummond
Journal:  FEBS Lett       Date:  1985-01-28       Impact factor: 4.124

7.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

8.  Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets.

Authors:  E G Lapetina; B Reep; B R Ganong; R M Bell
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  Evidence for the formation of inositol 4-monophosphate in stimulated human platelets.

Authors:  W Siess
Journal:  FEBS Lett       Date:  1985-06-03       Impact factor: 4.124

10.  The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets.

Authors:  M B Zucker; W Troll; S Belman
Journal:  J Cell Biol       Date:  1974-02       Impact factor: 10.539

View more
  5 in total

1.  Heterologous supersensitization between serotonin2 and alpha 2-adrenergic receptor-mediated intracellular calcium mobilization in human platelets.

Authors:  A Kagaya; M Mikuni; H Yamamoto; S Muraoka; S Yamawaki; K Takahashi
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Thrombin inhibits the pertussis-toxin-dependent ADP-ribosylation of a novel soluble Gi-protein in human platelets.

Authors:  J M Gennity; W Siess
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

3.  Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.

Authors:  Joen R Sheu; Tsorng H Fong; Cheng M Liu; Ming Y Shen; Ta L Chen; Yi Chang; Meng S Lu; George Hsiao
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

4.  Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.

Authors:  F Wang; U P Naik; Y H Ehrlich; S Osada; S Ohno; E Kornecki
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

5.  Association between central non-dipping pattern and platelet morphology in adults with type 1 diabetes without cardiovascular disease: a cross-sectional study.

Authors:  Michal Kulecki; Dariusz Naskret; Mikolaj Kaminski; Dominika Kasprzak; Pawel Lachowski; Daria Klause; Maria Kozlowska; Justyna Flotynska; Aleksandra Uruska; Dorota Zozulinska-Ziolkiewicz
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.